These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38946078)

  • 1. Implementing high-dose rate surface mould brachytherapy for carcinoma of eyelid: a practical approach and weekly review.
    Patro KC; Avinash A; Banidutta A; Kundu CR; Bhattacharya PS; Pilaka VKR; Muvvala M; Kumar AA; Aketi S; Karthikeyan K; Madasu BK; Vincent DT
    Radiat Oncol J; 2024 Jun; 42(2):154-159. PubMed ID: 38946078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.
    Vavassori A; Riva G; Durante S; Fodor C; Comi S; Cambria R; Cattani F; Spadola G; Orecchia R; Jereczek-Fossa BA
    J Contemp Brachytherapy; 2019 Oct; 11(5):443-448. PubMed ID: 31749853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HDR 192Ir brachytherapy in treatment of basal cell carcinoma of the lower eyelid and inner angle - our experience].
    Furdová A; Lukačko P; Lederleitner D
    Cesk Slov Oftalmol; 2013 Jun; 69(2):75-9. PubMed ID: 23964872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region.
    Budrukkar A; Dasgupta A; Pandit P; Laskar SG; Murthy V; Upreti RR; Gupta T; Dholam K; Agarwal JP
    J Contemp Brachytherapy; 2017 Jun; 9(3):242-250. PubMed ID: 28725248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report.
    Johnson SB; Prisciandaro JI; Zhou J; Hadley SW; Reynolds RK; Jolly S
    J Appl Clin Med Phys; 2014 Jan; 15(1):4520. PubMed ID: 24423851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting.
    Mukherji A; Sinnatamby M
    J Contemp Brachytherapy; 2017 Apr; 9(2):167-173. PubMed ID: 28533807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
    Lin L; Patel RR; Thomadsen BR; Henderson DL
    Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual multi-catheter mould technique in high-dose-rate brachytherapy - personalized approach in treating multifocal angiosarcoma of the face.
    Szlag M; Wojcieszek P; Kellas-Ślęczka S; Krysiak K; Cholewka A; Stąpór-Fudzińska M; Krzysztofiak T; Fijałkowski M
    J Contemp Brachytherapy; 2019 Aug; 11(4):337-342. PubMed ID: 31523234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial high-dose-rate brachytherapy in eyelid cancer.
    Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
    Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
    Hsu IC; Pickett B; Shinohara K; Krieg R; Roach M; Phillips T
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):851-8. PubMed ID: 10705005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience.
    Casey S; Awotwi-Pratt J; Bahl G
    Cureus; 2019 Dec; 11(12):e6412. PubMed ID: 31988814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial HDR Brachytherapy in the Treatment of Non-Melanocytic Skin Cancers around the Eye.
    Cisek P; Kieszko D; Bilski M; Dębicki R; Grywalska E; Hrynkiewicz R; Bębnowska D; Kordzińska-Cisek I; Rolińska A; Niedźwiedzka-Rystwej P; Grzybowska-Szatkowska L
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
    Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
    Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P; Schneider CJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of surface mould HDR brachytherapy with VMAT.
    Boman EL; Paterson DB; Pearson S; Naidoo N; Johnson C
    J Med Radiat Sci; 2018 Dec; 65(4):311-318. PubMed ID: 30105776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
    Zhang H; Donnelly ED; Strauss JB; Qi Y
    Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.